Opinion: The best way for the NIH to reduce drug prices is to address drug spending
The Senate might hold up the nomination of Monica Bertagnolli for NIH director for something that she can’t control.
As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica Bertagnolli as director of the National Institutes of Health unless she pledges to take specific steps to reduce drug prices.
However, the HELP Committee may want to focus on reducing drug spending, the product of price and units prescribed, rather than simply pricing.
What's Your Reaction?
